Tradestie Institutional Equity Comparison Engine
ENSC vs QNRX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENSC Overall Edge
ENSC Captures Institutional Edge (2โ1 Pillars ยท 4โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Momentum & Technical while QNRX counters with relative strength in Growth & Margin. Fundamentally, ENSC trades at 0.8x Forward P/E with -281.3% operating margin (-15.1% YoY revenue) versus QNRX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ENSC
ENSC 0.8x vs QNRX N/M Fwd P/E
Growth & Margin Winner
QNRX
Op Margin -281.3% vs 0.0% ยท YoY -15.1% vs +0.0%
Momentum & Technical Winner
ENSC
1Y -80.3% vs -82.0% ยท 52W Pos 8% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ENSC
NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap
$7.0M
1M Return
-29.55%
1Y Return
-80.33%
Forward P/E
0.8x
Unified AI Score
53.4 / 100
HOLD
Tech 50.0
Fund 62.0
Flow 50.0
Mom 60.0
QNRX
NASDAQ
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Pharmaceutical Preparations
$3.28
-2.35% 1D
Market Cap
$16.1M
1M Return
-18.2%
1Y Return
-81.96%
Forward P/E
N/M
Unified AI Score
46.1 / 100
HOLD
Tech 38.0
Fund 47.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ENSC -80.33%
QNRX -81.96%
Spread: +1.63 pp (ENSC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ENSC TTM Op. Margin: -281.3%
QNRX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ENSC vs QNRX. Trailing 12-month operating profitability (ENSC -281.3% vs QNRX 0.0%) and valuation multiples (ENSC 0.8x vs QNRX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ENSC | QNRX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.0M | $16.1M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 0.8x | 7.6x | Lower Multiple | ENSC |
| Forward P/E Ratio Valuation | 0.8x | N/M | Lower Multiple | ENSC |
| Revenue Growth (YoY) Growth | -15.1% | +0.0% | Higher Growth | QNRX |
| Operating Margin (TTM) Profitability | -281.3% | 0.0% | Higher Margin | QNRX |
| Net Profit Margin Profitability | -280.5% | 0.0% | Higher Margin | QNRX |
| Return on Equity (ROE) Capital Efficiency | -1295.1% | -142.6% | Higher ROE | QNRX |
| 52-Week Range Position Momentum | 8% ($0โ$2) | 0% ($3โ$24) | Stronger Trend | ENSC |
| Beta / 30D Volatility Risk Regime | 0.98ฮฒ ยท 79% Vol | 1.34ฮฒ ยท 74% Vol | Lower Realized Risk | QNRX |
| Unified Institutional Score Composite Signal | 53.4 / 100 (HOLD) | 46.1 / 100 (HOLD) | Higher Composite | ENSC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ENSC vs QNRX Buy Guide
ENSC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
QNRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ENSC nor QNRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.